» Articles » PMID: 20529913

Drug-target Interaction Prediction from Chemical, Genomic and Pharmacological Data in an Integrated Framework

Overview
Journal Bioinformatics
Specialty Biology
Date 2010 Jun 10
PMID 20529913
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: In silico prediction of drug-target interactions from heterogeneous biological data is critical in the search for drugs and therapeutic targets for known diseases such as cancers. There is therefore a strong incentive to develop new methods capable of detecting these potential drug-target interactions efficiently.

Results: In this article, we investigate the relationship between the chemical space, the pharmacological space and the topology of drug-target interaction networks, and show that drug-target interactions are more correlated with pharmacological effect similarity than with chemical structure similarity. We then develop a new method to predict unknown drug-target interactions from chemical, genomic and pharmacological data on a large scale. The proposed method consists of two steps: (i) prediction of pharmacological effects from chemical structures of given compounds and (ii) inference of unknown drug-target interactions based on the pharmacological effect similarity in the framework of supervised bipartite graph inference. The originality of the proposed method lies in the prediction of potential pharmacological similarity for any drug candidate compounds and in the integration of chemical, genomic and pharmacological data in a unified framework. In the results, we make predictions for four classes of important drug-target interactions involving enzymes, ion channels, GPCRs and nuclear receptors. Our comprehensively predicted drug-target interaction networks enable us to suggest many potential drug-target interactions and to increase research productivity toward genomic drug discovery.

Supplementary Information: Datasets and all prediction results are available at http://cbio.ensmp.fr/~yyamanishi/pharmaco/.

Availability: Softwares are available upon request.

Citing Articles

HPRNA: Predicting synergistic drug combinations for angina pectoris based on human pathway relationship network algorithm.

Zhou M, Xu M, Zhang X, Xing X, Li Y, Wang G PLoS One. 2025; 20(2):e0318368.

PMID: 39913435 PMC: 11801531. DOI: 10.1371/journal.pone.0318368.


MGACL: Prediction Drug-Protein Interaction Based on Meta-Graph Association-Aware Contrastive Learning.

Zhang P, Lin P, Li D, Wang W, Qi X, Li J Biomolecules. 2024; 14(10).

PMID: 39456200 PMC: 11505808. DOI: 10.3390/biom14101267.


CHL-DTI: A Novel High-Low Order Information Convergence Framework for Effective Drug-Target Interaction Prediction.

Wang S, Liu Y, Zhang Y, Zhang K, Song X, Zhang Y Interdiscip Sci. 2024; 16(3):568-578.

PMID: 38483753 DOI: 10.1007/s12539-024-00608-z.


Prediction of the active compounds and mechanism of Biochanin A in the treatment of Legg-Calvé-Perthes disease based on network pharmacology and molecular docking.

Liu J, Hua Z, Liao S, Li B, Tang S, Huang Q BMC Complement Med Ther. 2024; 24(1):26.

PMID: 38195507 PMC: 10775507. DOI: 10.1186/s12906-023-04298-w.


Optimization of drug-target affinity prediction methods through feature processing schemes.

Ru X, Zou Q, Lin C Bioinformatics. 2023; 39(11).

PMID: 37812388 PMC: 10636279. DOI: 10.1093/bioinformatics/btad615.


References
1.
Kaufmann B, Olcay A, Schaumann W, TEUFEL W, Weib W . Pharmacokinetics of metildigoxin and digoxin in geriatric patients with normal and elevated serum creatinine levels. Clin Pharmacokinet. 1981; 6(6):463-8. DOI: 10.2165/00003088-198106060-00004. View

2.
Dobson C . Chemical space and biology. Nature. 2004; 432(7019):824-8. DOI: 10.1038/nature03192. View

3.
Schomburg I, Chang A, Ebeling C, Gremse M, Heldt C, Huhn G . BRENDA, the enzyme database: updates and major new developments. Nucleic Acids Res. 2003; 32(Database issue):D431-3. PMC: 308815. DOI: 10.1093/nar/gkh081. View

4.
Ye J, Wang Q, Zhou X, Zhang N . Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm. 2007; 352(1-2):273-9. DOI: 10.1016/j.ijpharm.2007.10.014. View

5.
Rarey M, Kramer B, Lengauer T, Klebe G . A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 1996; 261(3):470-89. DOI: 10.1006/jmbi.1996.0477. View